Standardization of 13-color high-sensitivity measurable residual disease (MRD) assessment in B-cell lymphoblastic leukemia (B-ALL) treated with novel anti-CD19 immunotherapies by Prashant Tembhare, Priyanka Dhende, Vruksha Shetty, Simpy Raj, Sitaram Ghogale, Sweta Rajpal, Gaurav Chatterjie, Karisma Girase, Nikhil Patkar, Nilesh Deshpande, Chetan Dhamane, Gaurav Narula, P.G. Subramanian

Connect to this object online.